| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.4 | 8e-11 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.24 | 0.0001 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.22 | 0.002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.2 | 0.003 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.22 | 0.003 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.19 | 0.004 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.17 | 0.01 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.092 | 0.2 |